Jean-Claude Manuguerra

We established an Emerging Infectious Disease Research Center in Southeast Asia and West/Central Africa with an inter-continental one-health approach designed to improve the capacity to respond rapidly and effectively to outbreaks. We built on […]

AFRIPOX : une approche One Health de la variole du singe en République Centrafricaine

EVA-GLOBAL objective is to generate the largest accessible collection of human, animal and plant viruses in the world and move beyond the current state-of-the-art to provide an increasingly valuable resource and service to the […]

Le projet EBO-SURSY est financé par l’Union Européenne (UE) à hauteur de 8 millions d’euros. Il a été lancé le 15 janvier 2017 dans 10 pays prioritaires pour une période de 5 ans.   […]

With over 125 years’ experience with infectious diseases, the Institut Pasteur and the Institut Pasteur International Network (IPIN), which is composed of 33 research institutes in 26 countries and five continents, are ideally positioned […]

Groupe Arbovirus (GA) de l’Unité Environnement et Risques Infectieux a été créé en 2014. Le GA travaille sur les virus transmis par les arthropodes (Arbovirus), avec un intérêt pour les arbovirus émergents ou réémergents […]

Summary of the project More than 60% of infectious diseases in humans are caused by pathogens likewise circulating in domestic animals and wildlife. Most of these pathogens are viruses whose genome is an RNA […]

About PREDEMICS Infectious diseases have always been a threat to the human population, but since the end of World War II, medical progress fostered the hope that pathogens could be controlled if not eradicated […]

Preventing vector-borne diseases around the mediterranean and black sea regions by creating a One Health network of laboratories Countries of the Mediterranean and Black Sea regions share common public health issues and threats.  The MediLabSecure […]

Our main objective is to increase the knowledge regarding the human virome during homeostasis and diseases. We mainly focus on: immunocompromised patients, where new pathogens and new associations between known pathogens and diseases at found at higher frequency than […]